title: Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity.
abstract: Primary human hepatocytes (PHH) are the "gold standard" for in vitro toxicity tests. However, 2D PHH cultures have limitations that are due to a time-dependent dedifferentiation process visible by morphological changes closely connected to a decline of albumin production and CYP450 activity. The 3D in vitro culture corresponds to in vivo-like tissue architecture, which preserves functional characteristics of hepatocytes, and therefore can at least partially overcome the restrictions of 2D cultures. Consequently, several drug toxicities observed in vivo cannot be reproduced in 2D in vitro models, for example, the toxic effects of acetaminophen. The objective of this study was to identify molecular differences between 2D and 3D cultivation which explain the observed toxicity response. Our data demonstrated an increase in cell death after treatment with acetaminophen in 3D, but not in 2D cultures. Additionally, an acetaminophen concentration-dependent increase in the CYP2E1 expression level in 3D cultures was detected. However, during the treatment with 10 mM acetaminophen, the expression level of SOD gradually decreased in 3D cultures and was undetectable after 24 h. In line with these findings, we observed higher import/export rates in the membrane transport protein, multidrug resistance-associated protein-1, which is known to be specific for acetaminophen transport. The presented data demonstrate that PHH cultured in 3D preserve certain metabolic functions. Therefore, they have closer resemblance to the in vivo situation than PHH in 2D cultures. In consequence, 3D cultures will allow for a more accurate hepatotoxicity prediction in in vitro models in the future.
authors.affiliation: MRI, Department of Trauma Surgery, Technical University Munich, Munich, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Schyschka
authors.forename: J J Martínez
authors.initials: JJ
authors.lastname: Sánchez
authors.forename: Z
authors.initials: Z
authors.lastname: Wang
authors.forename: B
authors.initials: B
authors.lastname: Burkhardt
authors.forename: U
authors.initials: U
authors.lastname: Müller-Vieira
authors.forename: K
authors.initials: K
authors.lastname: Zeilinger
authors.forename: A
authors.initials: A
authors.lastname: Bachmann
authors.forename: S
authors.initials: S
authors.lastname: Nadalin
authors.forename: G
authors.initials: G
authors.lastname: Damm
authors.forename: A K
authors.initials: AK
authors.lastname: Nussler
mesh_terms: D000082:Acetaminophen / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D018929:Cell Culture Techniques / Q000379:methods*; D016923:Cell Death / Q000187:drug effects; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D022781:Hepatocytes / Q000166:cytology* / Q000187:drug effects*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics / Q000378:metabolism*; D061251:Primary Cell Culture / Q000379:methods; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D000082:Acetaminophen; D019392:Cytochrome P-450 CYP2E1; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D013482:Superoxide Dismutase; C421109:multidrug resistance-associated protein 1